Selected research
Industry Research
Roxithromycin Industry Research Report 2026
Market perspective
The global Roxithromycin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Roxithromycin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Roxithromycin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Roxithromycin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Roxithromycin include Zhejiang Zhenyuan Pharmaceutical, Johnson & Johnson, Bayer AG, Valeant Pharmaceutical International, Stiefel Laboratories, Sigma-Aldrich, Hygeia Laboratories, Hovione and Hetero Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Roxithromycin market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Roxithromycin Market by Company
Zhejiang Zhenyuan Pharmaceutical
Johnson & Johnson
Bayer AG
Valeant Pharmaceutical International
Stiefel Laboratories
Sigma-Aldrich
Hygeia Laboratories
Hovione
Hetero Healthcare
Galderma SA
Finecure Pharmaceuticals
Cipher
Allergan
Roxithromycin Segment by Type
Roxithromycin Tablets
Roxithromycin Granules
Roxithromycin Capsules
Roxithromycin Segment by Application
Respiratory Tract Infections
Urinary Infections
Soft Tissue Infections
Roxithromycin Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Roxithromycin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Roxithromycin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Roxithromycin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Roxithromycin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Roxithromycin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Roxithromycin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Roxithromycin Tablets
- Roxithromycin Granules
- Roxithromycin Capsules
Applications
- Respiratory Tract Infections
- Urinary Infections
- Soft Tissue Infections
Companies covered
- Zhejiang Zhenyuan Pharmaceutical
- Johnson & Johnson
- Bayer AG
- Valeant Pharmaceutical International
- Stiefel Laboratories
- Sigma-Aldrich
- Hygeia Laboratories
- Hovione
- Hetero Healthcare
- Galderma SA
- Finecure Pharmaceuticals
- Cipher
- Allergan
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Roxithromycin Market Size (2021-2032)
- 2.2.2 Global Roxithromycin Sales (2021-2032)
- 2.2.3 Global Roxithromycin Market Average Price (2021-2032)
- 2.3 Roxithromycin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Roxithromycin Tablets
- 2.3.3 Roxithromycin Granules
- 2.3.4 Roxithromycin Capsules
- 2.4 Roxithromycin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Respiratory Tract Infections
- 2.4.3 Urinary Infections
- 2.4.4 Soft Tissue Infections
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Roxithromycin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Roxithromycin Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Roxithromycin Revenue of Manufacturers (2021-2026)
- 3.4 Global Roxithromycin Average Price by Manufacturers (2021-2026)
- 3.5 Global Roxithromycin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Roxithromycin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Roxithromycin, Product Type & Application
- 3.8 Global Manufacturers of Roxithromycin, Established Date
- 3.9 Global Roxithromycin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhejiang Zhenyuan Pharmaceutical
- 4.1.1 Zhejiang Zhenyuan Pharmaceutical Company Information
- 4.1.2 Zhejiang Zhenyuan Pharmaceutical Business Overview
- 4.1.3 Zhejiang Zhenyuan Pharmaceutical Roxithromycin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhejiang Zhenyuan Pharmaceutical Roxithromycin Product Portfolio
- 4.1.5 Zhejiang Zhenyuan Pharmaceutical Recent Developments
- 4.2 Johnson & Johnson
- 4.2.1 Johnson & Johnson Company Information
- 4.2.2 Johnson & Johnson Business Overview
- 4.2.3 Johnson & Johnson Roxithromycin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Johnson & Johnson Roxithromycin Product Portfolio
- 4.2.5 Johnson & Johnson Recent Developments
- 4.3 Bayer AG
- 4.3.1 Bayer AG Company Information
- 4.3.2 Bayer AG Business Overview
- 4.3.3 Bayer AG Roxithromycin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Bayer AG Roxithromycin Product Portfolio
- 4.3.5 Bayer AG Recent Developments
- 4.4 Valeant Pharmaceutical International
- 4.4.1 Valeant Pharmaceutical International Company Information
- 4.4.2 Valeant Pharmaceutical International Business Overview
- 4.4.3 Valeant Pharmaceutical International Roxithromycin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Valeant Pharmaceutical International Roxithromycin Product Portfolio
- 4.4.5 Valeant Pharmaceutical International Recent Developments
- 4.5 Stiefel Laboratories
- 4.5.1 Stiefel Laboratories Company Information
- 4.5.2 Stiefel Laboratories Business Overview
- 4.5.3 Stiefel Laboratories Roxithromycin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Stiefel Laboratories Roxithromycin Product Portfolio
- 4.5.5 Stiefel Laboratories Recent Developments
- 4.6 Sigma-Aldrich
- 4.6.1 Sigma-Aldrich Company Information
- 4.6.2 Sigma-Aldrich Business Overview
- 4.6.3 Sigma-Aldrich Roxithromycin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sigma-Aldrich Roxithromycin Product Portfolio
- 4.6.5 Sigma-Aldrich Recent Developments
- 4.7 Hygeia Laboratories
- 4.7.1 Hygeia Laboratories Company Information
- 4.7.2 Hygeia Laboratories Business Overview
- 4.7.3 Hygeia Laboratories Roxithromycin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hygeia Laboratories Roxithromycin Product Portfolio
- 4.7.5 Hygeia Laboratories Recent Developments
- 4.8 Hovione
- 4.8.1 Hovione Company Information
- 4.8.2 Hovione Business Overview
- 4.8.3 Hovione Roxithromycin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hovione Roxithromycin Product Portfolio
- 4.8.5 Hovione Recent Developments
- 4.9 Hetero Healthcare
- 4.9.1 Hetero Healthcare Company Information
- 4.9.2 Hetero Healthcare Business Overview
- 4.9.3 Hetero Healthcare Roxithromycin Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Hetero Healthcare Roxithromycin Product Portfolio
- 4.9.5 Hetero Healthcare Recent Developments
- 4.10 Galderma SA
- 4.10.1 Galderma SA Company Information
- 4.10.2 Galderma SA Business Overview
- 4.10.3 Galderma SA Roxithromycin Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Galderma SA Roxithromycin Product Portfolio
- 4.10.5 Galderma SA Recent Developments
- 4.11 Finecure Pharmaceuticals
- 4.11.1 Finecure Pharmaceuticals Company Information
- 4.11.2 Finecure Pharmaceuticals Business Overview
- 4.11.3 Finecure Pharmaceuticals Roxithromycin Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Finecure Pharmaceuticals Roxithromycin Product Portfolio
- 4.11.5 Finecure Pharmaceuticals Recent Developments
- 4.12 Cipher
- 4.12.1 Cipher Company Information
- 4.12.2 Cipher Business Overview
- 4.12.3 Cipher Roxithromycin Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Cipher Roxithromycin Product Portfolio
- 4.12.5 Cipher Recent Developments
- 4.13 Allergan
- 4.13.1 Allergan Company Information
- 4.13.2 Allergan Business Overview
- 4.13.3 Allergan Roxithromycin Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Allergan Roxithromycin Product Portfolio
- 4.13.5 Allergan Recent Developments
5 Global Roxithromycin Market Scenario by Region
- 5.1 Global Roxithromycin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Roxithromycin Sales by Region: 2021-2032
- 5.2.1 Global Roxithromycin Sales by Region: 2021-2026
- 5.2.2 Global Roxithromycin Sales by Region: 2027-2032
- 5.3 Global Roxithromycin Revenue by Region: 2021-2032
- 5.3.1 Global Roxithromycin Revenue by Region: 2021-2026
- 5.3.2 Global Roxithromycin Revenue by Region: 2027-2032
- 5.4 North America Roxithromycin Market Facts & Figures by Country
- 5.4.1 North America Roxithromycin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Roxithromycin Sales by Country (2021-2032)
- 5.4.3 North America Roxithromycin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Roxithromycin Market Facts & Figures by Country
- 5.5.1 Europe Roxithromycin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Roxithromycin Sales by Country (2021-2032)
- 5.5.3 Europe Roxithromycin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Roxithromycin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Roxithromycin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Roxithromycin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Roxithromycin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Roxithromycin Market Facts & Figures by Country
- 5.7.1 South America Roxithromycin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Roxithromycin Sales by Country (2021-2032)
- 5.7.3 South America Roxithromycin Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Roxithromycin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Roxithromycin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Roxithromycin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Roxithromycin Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Roxithromycin Sales by Type (2021-2032)
- 6.1.1 Global Roxithromycin Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Roxithromycin Sales Market Share by Type (2021-2032)
- 6.2 Global Roxithromycin Revenue by Type (2021-2032)
- 6.2.1 Global Roxithromycin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Roxithromycin Revenue Market Share by Type (2021-2032)
- 6.3 Global Roxithromycin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Roxithromycin Sales by Application (2021-2032)
- 7.1.1 Global Roxithromycin Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Roxithromycin Sales Market Share by Application (2021-2032)
- 7.2 Global Roxithromycin Revenue by Application (2021-2032)
- 7.2.1 Global Roxithromycin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Roxithromycin Revenue Market Share by Application (2021-2032)
- 7.3 Global Roxithromycin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Roxithromycin Value Chain Analysis
- 8.1.1 Roxithromycin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Roxithromycin Production Mode & Process
- 8.2 Roxithromycin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Roxithromycin Distributors
- 8.2.3 Roxithromycin Customers
9 Global Roxithromycin Analyzing Market Dynamics
- 9.1 Roxithromycin Industry Trends
- 9.2 Roxithromycin Industry Drivers
- 9.3 Roxithromycin Industry Opportunities and Challenges
- 9.4 Roxithromycin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst